Andrea Papadia1, Sara Imboden2, Maria Luisa Gasparri2,3, Franziska Siegenthaler2, Anja Fink2, Michael D Mueller2. 1. Department of Obstetrics and Gynecology, University Hospital of Berne and University of Berne, Effingerstrasse 102, 3010, Bern, Switzerland. andrea.papadia@insel.ch. 2. Department of Obstetrics and Gynecology, University Hospital of Berne and University of Berne, Effingerstrasse 102, 3010, Bern, Switzerland. 3. Department of Gynecology and Obstetrics, Sapienza University of Rome, Rome, Italy.
Abstract
PURPOSE: The adoption of a sentinel lymph node (SLN) algorithm and the presence of high bilateral detection rates have been associated with increased accuracy of SLN mapping in cervical and endometrial cancer patients. In this context, the significance of the number of SLNs removed has not yet been investigated. The aim of this study was to evaluate (a) whether or not a higher SLN removal count is associated with a reduced false-negative rate and (b) which clinical factors correlate with the number of SLNs removed. METHODS: Patients with cervical or endometrial cancer who underwent SLN mapping with bilateral SLN detection followed by lymphadenectomy were evaluated retrospectively. On the basis of the mean number of the SLNs removed, the patients were divided in two groups: Group 1 included patients with up to 3 SLNs removed and Group 2 included patients with more than 3 SLNs removed. Factors predicting a higher SLN count were evaluated using univariate and multivariate analysis. RESULTS: Eighty-four patients met the inclusion criteria. The two groups consisted of 42 patients each and differed only by the median SLN count. Two endometrial cancer patients in Group 1 had false-negative pelvic SLNs and isolated para-aortic metastases; no false-negative SLNs were recorded in Group 2 (p = n.s.). The results of multivariate analysis indicted that the number of SLNs removed was influenced only in cases where the operating surgeon had performed more than 20 laparoscopic ICG SLN mappings. CONCLUSIONS: A higher SLN count does not seem to increase the accuracy of SLN mapping in cervical and endometrial cancer patients.
PURPOSE: The adoption of a sentinel lymph node (SLN) algorithm and the presence of high bilateral detection rates have been associated with increased accuracy of SLN mapping in cervical and endometrial cancerpatients. In this context, the significance of the number of SLNs removed has not yet been investigated. The aim of this study was to evaluate (a) whether or not a higher SLN removal count is associated with a reduced false-negative rate and (b) which clinical factors correlate with the number of SLNs removed. METHODS:Patients with cervical or endometrial cancer who underwent SLN mapping with bilateral SLN detection followed by lymphadenectomy were evaluated retrospectively. On the basis of the mean number of the SLNs removed, the patients were divided in two groups: Group 1 included patients with up to 3 SLNs removed and Group 2 included patients with more than 3 SLNs removed. Factors predicting a higher SLN count were evaluated using univariate and multivariate analysis. RESULTS: Eighty-four patients met the inclusion criteria. The two groups consisted of 42 patients each and differed only by the median SLN count. Two endometrial cancerpatients in Group 1 had false-negative pelvic SLNs and isolated para-aortic metastases; no false-negative SLNs were recorded in Group 2 (p = n.s.). The results of multivariate analysis indicted that the number of SLNs removed was influenced only in cases where the operating surgeon had performed more than 20 laparoscopic ICG SLN mappings. CONCLUSIONS: A higher SLN count does not seem to increase the accuracy of SLN mapping in cervical and endometrial cancerpatients.
Authors: J How; W H Gotlieb; J Z Press; J Abitbol; M Pelmus; A Ferenczy; S Probst; R Gotlieb; S Brin; S Lau Journal: Gynecol Oncol Date: 2015-04-12 Impact factor: 5.482
Authors: Ilary Ruscito; Maria Luisa Gasparri; Elena Ioana Braicu; Filippo Bellati; Luigi Raio; Jalid Sehouli; Michael D Mueller; Pierluigi Benedetti Panici; Andrea Papadia Journal: Ann Surg Oncol Date: 2016-05-09 Impact factor: 5.344
Authors: Sanjeev Kumar; Fabiola Medeiros; Sean C Dowdy; Gary L Keeney; Jamie N Bakkum-Gamez; Karl C Podratz; William A Cliby; Andrea Mariani Journal: Gynecol Oncol Date: 2012-08-29 Impact factor: 5.482
Authors: Edward J Tanner; Abdulrahman K Sinno; Rebecca L Stone; Kimberly L Levinson; Kara C Long; Amanda N Fader Journal: Gynecol Oncol Date: 2015-06-19 Impact factor: 5.482
Authors: W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts Journal: J Clin Oncol Date: 2000-04 Impact factor: 44.544
Authors: Andrea Papadia; Sara Imboden; Franziska Siegenthaler; Maria Luisa Gasparri; Stefan Mohr; Susanne Lanz; Michael D Mueller Journal: Ann Surg Oncol Date: 2016-01-20 Impact factor: 5.344
Authors: Maria Luisa Gasparri; Donatella Caserta; Pierluigi Benedetti Panici; Andrea Papadia; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2018-11-20 Impact factor: 4.553
Authors: Andrea Papadia; Maria Luisa Gasparri; Sophie Genoud; Klaeser Bernd; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2017-07-01 Impact factor: 4.553
Authors: Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2017-08-21 Impact factor: 4.553
Authors: Andrea Papadia; Maria Luisa Gasparri; Franziska Siegenthaler; Sara Imboden; Stefan Mohr; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2016-11-11 Impact factor: 4.553
Authors: Jeffery Chakedis; Lawrence A Shirley; Alicia M Terando; Roman Skoracki; John E Phay Journal: Ann Surg Oncol Date: 2018-08-03 Impact factor: 5.344
Authors: Andrea Papadia; Maria Luisa Gasparri; Anda P Radan; Chantal A L Stämpfli; Tilman T Rau; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2018-04-24 Impact factor: 4.553
Authors: Andrea Papadia; Alessandro Buda; Maria Luisa Gasparri; Giampaolo Di Martino; Beatrice Bussi; Debora Verri; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2018-07-24 Impact factor: 4.553
Authors: Franziska Siegenthaler; Sara Imboden; Laura Knabben; Stefan Mohr; Andrea Papadia; Michael D Mueller Journal: Front Oncol Date: 2021-04-22 Impact factor: 6.244